The Biden administration plans to require Medicare and Medicaid to offer coverage of weight loss medications for people seeking obesity treatment.The new rule, which was proposed by the administration ...

The Biden administration is proposing a new rule to significantly expand the coverage of weight-loss drugs for Americans on ...

The diabetes drug, Ozempic, has been in the headlines, causing quite a stir. Senior writer for Drugwatch.com, Terry Turner, ...

The Biden administration has announced a new proposal that would get Medicare and Medicaid to cover popular weight loss drugs ...

The Federal Drug Administration (FDA) is warning consumers about unapproved semaglutide, a popular weight loss drug associated with the brand names Ozempic and Wegovy.

About 42% of U.S. adults are obese, the CDC says. GLP-1 medications have changed the picture for people hoping to reduce ...

Popular weight-loss drugs like Wegovy or Ozempic would be covered by Medicare or Medicaid under a newly-proposed rule by the ...

Millions of obese Americans would get access to popular weekly injectables that would help them shed pounds quickly if a $35 ...

Millions of obese Americans would be eligible to have drugs like Wegovy or Zepbound covered by Medicare or Medicaid under the ...

The Biden administration proposed a rule to let Medicare and Medicaid cover obesity drugs like Ozempic. Millions would ...

The proposal would expand coverage of anti-obesity drugs to 7.5 million people covered by Medicare and Medicaid, the Biden ...

If the proposal is finalized, it could set the stage for a showdown between the pharmaceutical industry and the Trump ...